Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 2

2(28.6%)

7Total

N/A(5)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT07555301Not Yet Recruiting

Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy

Role: lead

NCT06921681Not ApplicableRecruiting

Ultrasound-guided Cryobiopsy of Mediastinal/Hilar Lymph Nodes

Role: collaborator

NCT03643367Phase 2Not Yet Recruiting

Sevoflurane Sedation in Patients With Septic Shock

Role: collaborator

NCT05517369Not ApplicableWithdrawn

Impact of Hybrid-ESD+ and LiftUp® on the en Bloc/R0 Rate in Colorectal Adenomas Between 2 and 3 cm

Role: collaborator

NCT05111184Not ApplicableUnknown

Educational Impact of a Tablet Application on Nutrition in Maintenance Hemodialysis Patients

Role: lead

NCT02663336Unknown

Prevalence of Masked Hypertension in Nephrological Patients

Role: lead

NCT03692988Not ApplicableCompleted

Dignity Therapy for Patients With Early Dementia and Their Family

Role: collaborator

NCT01039922Recruiting

SwissNET - a Registry for Neuroendocrine Tumours in Switzerland

Role: collaborator

NCT02279316Not ApplicableCompleted

Move for Your Mind - Pilot Trial

Role: collaborator

NCT00944684Phase 2Completed

High Dose Ribavirin in the Treatment of Chronic Hepatitis C

Role: collaborator

All 10 trials loaded